Literature DB >> 25017008

A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.

Eun Kyoung Lee1, Sang-Yoon Lee, Hyeong Gon Yu.   

Abstract

BACKGROUND: To develop a grading system for sunset glow fundus (SGF) based on the results of ultra-wide field retinal imaging and to investigate the factors related to the severity of SGF in patients with Vogt-Koyanagi-Harada (VKH) disease.
METHODS: Records of 55 eyes with VKH disease were retrospectively reviewed. All patients had undergone serial fundus photography, ultra-wide field retinal imaging and spectral-domain optical coherence tomography. The morphologic characteristics of SGF and associated features related to the severity of the condition were evaluated.
RESULTS: Sunset glow fundi were classified into 3 groups based on the extent and severity of depigmentary changes: early (n = 7), intermediate (n = 10) and advanced (n = 20). Grade 0 indicates the absence of sunset glow appearance. Eyes with a higher SGF grade were more likely to exhibit chronic recurrence (P < 0.001) and an anterior chamber reaction ≥ 2+ (P < 0.001), and were less likely to exhibit exudative retinal detachment (P < 0.001) at the initial presentation. Higher grades were more likely to exhibit cataracts (P < 0.001), glaucoma (P = 0.010), patchy chorioretinal atrophic lesions (P = 0.012), depigmented atrophic lesions (P < 0.001), an increased peripapillary atrophy/disc area ratio (P < 0.001), a decreased subfoveal choroidal thickness (P < 0.001), more frequent uveitis recurrences (P = 0.012) and a longer disease duration (P < 0.001). SGF progression was faster in eyes with a longer active inflammatory period.
CONCLUSIONS: We present a simple and logical grading system for SGF as determined by using ultra-wide field retinal imaging. This grading system offers a means of assessing the degree of inflammation and facilitates speculation about the duration of VKH disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25017008     DOI: 10.1007/s00417-014-2710-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.

Authors:  Ya-Ling Guo; Yi Du; Jian-Feng He
Journal:  Am J Ophthalmol       Date:  2009-05       Impact factor: 5.258

Review 2.  Free radical mediated photoreceptor damage in uveitis.

Authors:  N A Rao; G S Wu
Journal:  Prog Retin Eye Res       Date:  2000-01       Impact factor: 21.198

3.  Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.

Authors:  A Jap; C D Luu; I Yeo; S-P Chee
Journal:  Eye (Lond)       Date:  2006-09-15       Impact factor: 3.775

4.  Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease.

Authors:  S Suzuki
Journal:  Jpn J Ophthalmol       Date:  1999 Jul-Aug       Impact factor: 2.447

5.  Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.

Authors:  H Inomata; N A Rao
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

6.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group.

Authors:  G N Holland; W C Buhles; B Mastre; H J Kaplan
Journal:  Arch Ophthalmol       Date:  1989-12

8.  Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.

Authors:  Ahmed M Abu El-Asrar; Mamdouh Al Tamimi; Suhail Hemachandran; Hani S Al-Mezaine; Abdulrahman Al-Muammar; Dustan Kangave
Journal:  Acta Ophthalmol       Date:  2013-04-10       Impact factor: 3.761

9.  Choroidal thickness in convalescent vogt-koyanagi-harada disease.

Authors:  Hiroyuki Takahashi; Hiroshi Takase; Atsuko Ishizuka; Masaru Miyanaga; Tatsushi Kawaguchi; Kyoko Ohno-Matsui; Manabu Mochizuki
Journal:  Retina       Date:  2014-04       Impact factor: 4.256

10.  Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.

Authors:  Narsing A Rao; Amod Gupta; Laurie Dustin; Soon Phaik Chee; Annabelle A Okada; Moncef Khairallah; Bahram Bodaghi; Phuc Lehoang; Massimo Accorinti; Manabu Mochizuki; Tisha Prabriputaloong; Russell W Read
Journal:  Ophthalmology       Date:  2009-12-24       Impact factor: 12.079

View more
  7 in total

1.  Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.

Authors:  Viviane Mayumi Sakata; Marcelo Mendes Lavezzo; Felipe T da Silva; Ever Ernesto Caso Rodriguez; Celso Morita; Smairah Frutuoso Abdallah; Maria Kiyoko Oyamada; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-22       Impact factor: 3.117

2.  The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.

Authors:  Un Chul Park; In Hwan Cho; Eun Kyung Lee; Hyeong Gon Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-05       Impact factor: 3.117

3.  Differences in photoreceptor recovery among patients and between different parts of the posterior pole in Vogt-Koyanagi-Harada disease.

Authors:  M Zhou; R P Gu; Z Sun; C H Jiang; Q Chang; G Z Xu
Journal:  Eye (Lond)       Date:  2017-11-17       Impact factor: 3.775

Review 4.  Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.

Authors:  Carl P Herbort; Ahmed M Abu El Asrar; Joyce H Yamamoto; Carlos E Pavésio; Vishali Gupta; Moncef Khairallah; Ilknur Tugal-Tutkun; Masoud Soheilian; Masuru Takeuchi; Marina Papadia
Journal:  Int Ophthalmol       Date:  2016-11-14       Impact factor: 2.031

Review 5.  Ultra-wide field retinal imaging: A wider clinical perspective.

Authors:  Vinod Kumar; Abhidnya Surve; Devesh Kumawat; Brijesh Takkar; Shorya Azad; Rohan Chawla; Daraius Shroff; Atul Arora; Ramandeep Singh; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

6.  Objective evaluation of choroidal melanin loss in patients with Vogt-Koyanagi-Harada disease using polarization-sensitive optical coherence tomography.

Authors:  Masahiro Miura; Shuichi Makita; Yoshiaki Yasuno; Shinnosuke Azuma; Toshihiro Mino; Tatsuo Yamaguchi; Takuya Iwasaki; Rei Nemoto; Hiroyuki Shimizu; Hiroshi Goto
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

Review 7.  Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease.

Authors:  Cristhian A Urzua; Carl Herbort; Rodrigo A Valenzuela; Ahmed M Abu El-Asrar; Lourdes Arellanes-Garcia; Ariel Schlaen; Joyce Yamamoto; Carlos Pavesio
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.